ENG and familial pancreatic carcinoma: Based on this and the fact that CD105 is a druggable target, we hypothesized that PCI-controlled drug delivery of the immunotoxin anti-CD105-saporin would be an efficient and specific strategy to target and kill these 5-FU resistant pancreatic cancer cell lines.